🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate, in 18-55 year old adults, the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-09
Trial ID
NCT00453986
Treatments Being Tested
In this study, the concentration of antibody to the vaccine one year, three...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-10-20
Trial ID
NCT00718666
Treatments Being Tested
Subjects were previously vaccinated at 11 to 17 years of age. This extensio...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09
Trial ID
NCT00974363
Treatments Being Tested
The purpose of this study is to demonstrate, in 11-17 year old subjects, th...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-02
Trial ID
NCT00464815
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, safety and react...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-10
Trial ID
NCT01767376
Treatments Being Tested
This study evaluates the immunogenicity and safety of the meningococcal con...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-11-30
Trial ID
NCT01235975
Treatments Being Tested
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested
The purpose of the study is to characterize the immunogenicity \& safety of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-13
Trial ID
NCT00614614
This study evaluates the immunogenicity and safety of the meningococcal con...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01-27
Trial ID
NCT01340898
Treatments Being Tested
The purpose of the study is to evaluate the persistence of the immune respo...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-03
Trial ID
NCT01266993
Treatments Being Tested